Pick Topic
Review Topic
List Experts
Examine Expert
Save Expert
  Site Guide ··   
Expertise in Melanoma: HELP
Llúcia Alós
Based on 18 articles published since 2009
(Why 18 articles?)
||||
Expertise Level
The expertise of Llúcia Alós ranks in the
  • Top 2.9%
  • ... of 106,334 published authors worldwide on Melanoma
  • ... from 2009 through 2019
  • ... based on contributions to 18 articles on the topic.
Graphical view (beta)
Aliases Alos, Llucìa   ·   Alós, Llúcia   ·   Alos, Llucia   ·   Alos, Llúcia   ·   Alós, Llucia
Work Locations
Details
Most likely:    Universitat de Barcelona      
2018
  • Dermatology Department, Hospital Universitari Germans Trial i Pujol, Badalona, Universitat Autònoma de Barcelona, Spain. · Dermatology Department, Instituto Dermatológico GlobalDerm, Palma del Río, Córdoba, Spain. · Medical Sciences Department, Section of Dermatology, University of Turin, Italy. · Melanoma Unit, Dermatology Department, Hospital Clinic, Universitat de Barcelona, Institut d'investigacions biomèdiques August Pi i Sunyer (IDIBAPS), Barcelona, Spain. · Centro de Investigación Biomédica en Red (CIBER) de Enfermedades Raras, Barcelona, Spain. · Melanoma Unit, Medical-&-Surgical Dermatology Department, Hospital Universitario Virgen Macarena, Sevilla, Spain. · Unidad de Investigación, Fundación Piel Sana, Academia Española de Dermatología, Madrid, Spain. · Nuclear Medicine Department, Hospital Clinic Barcelona, Universitat de Barcelona, Institut d'investigacions biomèdiques August Pi i Sunyer (IDIBAPS), Barcelona, Spain. · Surgery Department, Hospital Clinic, Barcelona, Spain. · Pathology Department, Hospital Clinic, Universidad de Barcelona, Barcelona, Spain. · Dermatology Department, Instituto Valenciano de Oncología, Valencia, Spain. · Surgery Department, Instituto Valenciano de Oncología, Valencia, Spain. · Pathology Department, Instituto Valenciano de Oncología, Valencia, Spain. · Otorhinolaringology Department, Instituto Valenciano de Oncología, Valencia, Spain. · Pathology Department, Hospital Universitari Germans Trial i Pujol, Badalona, Spain. · Surgery Department, Hospital Universitari Germans Trial i Pujol, Badalona, Spain. · Medical Oncology Department, Institut Català d'Oncologia, Hospital Universitari Germans Trial i Pujol, Badalona, Spain. · Grupo de Investigación, Unidad de Gestión Clínica de Dermatología Médico-Quirúrgica, Hospital Universitario Virgen Macarena, Sevilla, Spain. · Pubmed 28960289
2017
  • Translational Genomics and Targeted Therapeutics in Solid Tumors, August Pi i Sunyer Biomedical Research Institute (IDIBAPS), Barcelona, Spain. · Medical Oncology Department, Hospital Clínic of Barcelona, Barcelona, Spain. · Translational Genomics Group, Vall d'Hebron Institute of Oncology (VHIO), Barcelona, Spain. · Medical Oncology Department, Vall d'Hebron Hospital, Barcelona, Spain. · Translational Genomics and Targeted Therapeutics in Solid Tumors, August Pi i Sunyer Biomedical Research Institute (IDIBAPS), Barcelona, Spain. · Molecular Oncology Group, Vall d'Hebron Institute of Oncology (VHIO), Barcelona, Spain. · Pathology Department, Hospital Clínic of Barcelona, Barcelona, Spain. · Department of Bioinformatics, Lineberger Comprehensive Cancer Center, Chapel Hill, North Carolina. · Cancer Genomics Group, Vall d'Hebron Institute of Oncology (VHIO), Barcelona, Spain. · Pubmed 28487385
2016
  • Hospital Clinic I Provincial de Barcelona, Universitat de Barcelona and Institut d'Investigacions Biomèdiques August Pi i Sunyer, Barcelona, Spain2Department of Dermatology, Post-Graduation Program in Pathology, Universidade Federal de Ciências da Saúde de Porto Alegre, Porto Alegre, Brazil3Pontifícia Universidade Católica do Rio Grande do Sul, School of Medicine, Porto Alegre, Brazil. · Hospital Clinic I Provincial de Barcelona, Universitat de Barcelona and Institut d'Investigacions Biomèdiques August Pi i Sunyer, Barcelona, Spain. · Department of Dermatology, Post-Graduation Program in Pathology, Universidade Federal de Ciências da Saúde de Porto Alegre, Porto Alegre, Brazil. · Hospital Clinic I Provincial de Barcelona, Universitat de Barcelona and Institut d'Investigacions Biomèdiques August Pi i Sunyer, Barcelona, Spain4Centro de Investigación Biomédica en Red en Enfermedades Raras, Barcelona, Spain. · Pubmed 27579522
  • Melanoma Unit, Dermatology Department, Hospital Clínic & IDIBAPS (Institut d'Investigacions Biomèdiques August Pi i Sunyer), Barcelona, Spain. · Department of Pathology, Hospital Clínic de Barcelona, Barcelona, Spain; Universitat de Barcelona, Barcelona, Spain. · Melanoma Unit, Dermatology Department, Hospital Clínic & IDIBAPS (Institut d'Investigacions Biomèdiques August Pi i Sunyer), Barcelona, Spain; Centro Investigación Biomédica en Red de Enfermedades Raras (CIBERER), Instituto de Salud Carlos III (ISCIII), Barcelona, Spain; Universitat de Barcelona, Barcelona, Spain. · Melanoma Unit, Dermatology Department, Hospital Clínic & IDIBAPS (Institut d'Investigacions Biomèdiques August Pi i Sunyer), Barcelona, Spain; Centro Investigación Biomédica en Red de Enfermedades Raras (CIBERER), Instituto de Salud Carlos III (ISCIII), Barcelona, Spain; Universitat de Barcelona, Barcelona, Spain. Electronic address: · Pubmed 27185448
2015
  • Melanoma Unit, Department of Dermatology, Hospital Clínic, Institut d'Investigacions Biomèdiques August Pi i Sunyer, University of Barcelona, Barcelona, Spain2Centro de Investigación Biomédica en Red en Enfermedades Raras, Instituto de Salud Carlos III, B. · Centro de Investigación Biomédica en Red en Enfermedades Raras, Instituto de Salud Carlos III, Barcelona, Spain3Department of Biochemical and Molecular Genetics, Hospital Clínic, Institut d'Investigacions Biomèdiques August Pi i Sunyer, University of Barc. · Department of Pathology, Hospital Clínic, Institut d'Investigacions Biomèdiques August Pi i Sunyer, University of Barcelona, Barcelona, Spain. · Pubmed 25651238
  • Melanoma Unit, Dermatology Department, Hospital Clinic of Barcelona, Barcelona, Spain; August Pi i Sunyer Biomedical Research Institute (IDIBAPS), Barcelona, Spain. · Pathology Department, Hospital Clinic of Barcelona, Barcelona, Spain. · Melanoma Unit, Dermatology Department, Hospital Clinic of Barcelona, Barcelona, Spain; August Pi i Sunyer Biomedical Research Institute (IDIBAPS), Barcelona, Spain; Centre of Biomedical Research on Rare Diseases (CIBERER), ISCIII, Barcelona, Spain. · Melanoma Unit, Dermatology Department, Hospital Clinic of Barcelona, Barcelona, Spain; August Pi i Sunyer Biomedical Research Institute (IDIBAPS), Barcelona, Spain; Centre of Biomedical Research on Rare Diseases (CIBERER), ISCIII, Barcelona, Spain; Department of Medicine, Universitat de Barcelona, Spain. Electronic address: · Pubmed 25500039
2014
  • Dermatology Department, Melanoma Unit, Hospital Clinic of Barcelona, Barcelona, Spain; Institut de Recerca Biomédica August Pi i Sunyer (IDIBAPS), Barcelona, Spain. · Dermatology Department, Melanoma Unit, Hospital Clinic of Barcelona, Barcelona, Spain; Institut de Recerca Biomédica August Pi i Sunyer (IDIBAPS), Barcelona, Spain; Centro de Investigación Biomédica en Red de Enfermedades Raras (CIBERER), Instituto de Salud Carlos III (ISCIII), Barcelona, Spain. · Pathology Department, Melanoma Unit, Hospital Clinic of Barcelona, Barcelona, Spain; Universitat de Barcelona, Barcelona, Spain. · Pathology Department, Melanoma Unit, Hospital Clinic of Barcelona, Barcelona, Spain. · Dermatology Department, Melanoma Unit, Hospital Clinic of Barcelona, Barcelona, Spain; Institut de Recerca Biomédica August Pi i Sunyer (IDIBAPS), Barcelona, Spain; Centro de Investigación Biomédica en Red de Enfermedades Raras (CIBERER), Instituto de Salud Carlos III (ISCIII), Barcelona, Spain; Universitat de Barcelona, Barcelona, Spain. Electronic address: · Pubmed 24725478
  • Department of Pathology, Hospital Clínic, IDIBAPS, University of Barcelona, Barcelona, Spain. · Department of Biochemical and Molecular Genetics, Hospital Clínic, IDIBAPS, University of Barcelona, Barcelona, Spain; Center for Biomedical Network Research on Rare Diseases (CIBERER), the Carlos III Institute of Health (ISCIII), Barcelona, Spain. · Center for Biomedical Network Research on Rare Diseases (CIBERER), the Carlos III Institute of Health (ISCIII), Barcelona, Spain; Department of Dermatology, Hospital Clínic, IDIBAPS, University of Barcelona, Barcelona, Spain. · Joseph Carreras Institute for Research against Leukemia, Hospital "Germans Trias i Pujol", Autonomous University of Barcelona, Barcelona, Spain. · Department of Pathology, Hospital Clínic, IDIBAPS, University of Barcelona, Barcelona, Spain. Electronic address: · Pubmed 24374110
  • Department of Pathology, Hospital Clínic, IDIBAPS, University of Barcelona, Spain. · Department of Biochemical and Molecular Genetics, Hospital Clínic, IDIBAPS, University of Barcelona, Spain; Centro Investigación Biomédica en Enfermedades Raras (CIBERER), Instituto de Salud Carlos III (ISCIII), Barcelona, Spain. · Institute of Predictive and Personalized Medicine of Cancer (IMPPC), Badalona, Spain. · Melanoma Unit, Department of Dermatology, Hospital Clínic, IDIBAPS, University of Barcelona, Spain; Centro Investigación Biomédica en Enfermedades Raras (CIBERER), Instituto de Salud Carlos III (ISCIII), Barcelona, Spain. · Institut de Recerca contra la Leucèmia Josep Carreras, Hospital Germans Trias i Pujol, Universitat Autònoma de Barcelona, Badalona, Spain. · Department of Pathology, Hospital Clínic, IDIBAPS, University of Barcelona, Spain. Electronic address: · Pubmed 25219713
2017
  • aMelanoma Unit, Department of Dermatology bMelanoma Unit, Department of Pathology cBiochemical and Molecular Genetics Service, Melanoma Unit, Hospital Clinic, Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS) dRadiotherapeutic Oncology Service, Melanoma Unit eGeneral Surgery Service, Melanoma Unit fImaging Diagnostic Center, CDI (Radiology and Nuclear Medicine Services), Melanoma Unit, Hospital Clinic gBiomedical Research Center for Rare Diseases, CIBERER. Insituto de Salud Carlos III hMedicine Department, University of Barcelona, Barcelona, Spain. · Pubmed 28296711
  • Dermatology Department, Melanoma Unit, Hospital Clinic and IDIBAPS (Institut d'Investigacions Biomèdiques August Pi i Sunyer, Barcelona, Spain. · Pubmed 27353949
2015
  • Melanoma Unit, Dermatology Department, Hospital Clinic of Barcelona, IDIBAPS, Barcelona, Spain. · Pubmed 25394499
2013
  • Melanoma Unit, Department of Dermatology, Hospital Clinic, Institut d'Investigacions Biomèdiques August Pi i Sunyer, Barcelona, Spain2Centro de Investigacion Biomedica en Red Enfermedades Raras, Instituto de Salud Carlos III, Barcelona, Spain. · Pubmed 23863988
2012
  • Melanoma Unit, Dermatology Department, Hospital Clìnic of Barcelona, IDIBAPS, Barcelona, Spain. · Pubmed 22521205
2011
  • Department of Pathology, Hospital Clínic, Institut d'Investigacions Biomèdiques August Pi i Sunyer, University of Barcelona, Spain. · Pubmed 21997694
  • Melanoma Unit, Department of Dermatology, Hospital Clinic of Barcelona, Institut d'investigacions Biomèdiques August Pi i Sunyer, Barcelona, Spain. · Pubmed 21281387
  • Department of Dermatology, Melanoma and Dermatopathology Units, Hospital Clínic de Barcelona, Universitat de Barcelona, Barcelona, Spain. · Pubmed 21240454
Possible:    Instituto de Salud Carlos III      
2017
  • aMelanoma Unit, Department of Dermatology bMelanoma Unit, Department of Pathology cBiochemical and Molecular Genetics Service, Melanoma Unit, Hospital Clinic, Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS) dRadiotherapeutic Oncology Service, Melanoma Unit eGeneral Surgery Service, Melanoma Unit fImaging Diagnostic Center, CDI (Radiology and Nuclear Medicine Services), Melanoma Unit, Hospital Clinic gBiomedical Research Center for Rare Diseases, CIBERER. Insituto de Salud Carlos III hMedicine Department, University of Barcelona, Barcelona, Spain. · Pubmed 28296711
Specific Interests

In the titles of their published articles, experts often reveal their very specific interests.

Here are the titles of the 10 most recent articles (out of 18 total) written by Llúcia Alós about Melanoma:

  • Sentinel lymph node biopsy versus observation in thick melanoma: A multicenter propensity score matching study. 2018
  • Immune-Related Gene Expression Profiling After PD-1 Blockade in Non-Small Cell Lung Carcinoma, Head and Neck Squamous Cell Carcinoma, and Melanoma. 2017
  • Prognostic role of the histological subtype of melanoma on the hands and feet in Caucasians. 2017
  • Development of Cutaneous Toxicities During Selective Anti-BRAF Therapies: Preventive Role of Combination with MEK Inhibitors. 2017
  • Association Between Confocal Morphologic Classification and Clinical Phenotypes of Multiple Primary and Familial Melanomas. 2016
  • The challenging diagnosis of eccrine poromas. 2016
  • Time and tumor type (primary or metastatic) do not influence the detection of BRAF/NRAS mutations in formalin fixed paraffin embedded samples from melanomas. 2016
  • Multiple BRAF Wild-Type Melanomas During Dabrafenib Treatment for Metastatic BRAF-Mutant Melanoma. 2015
  • In vivo characterization of solitary angiokeratoma by reflectance confocal microscopy and high definition optical coherence tomography. 2015
  • Dermoscopy of Naevus-associated Melanomas. 2015
Show List of Full Article Records
Google Searches

Learn more about Llúcia Alós using the ready-made Google searches below.
This is essential! -- Publications never tell the whole story!

General Search:
Universitat de Barcelona
Instituto de Salud Carlos III
Affiliation Timeline
Click for institutional directory in table below. (Not always available.)
What is this?
Universitat de Barcelona
2018
  • Dermatology Department, Hospital Universitari Germans Trial i Pujol, Badalona, Universitat Autònoma de Barcelona, Spain. · Dermatology Department, Instituto Dermatológico GlobalDerm, Palma del Río, Córdoba, Spain. · Medical Sciences Department, Section of Dermatology, University of Turin, Italy. · Melanoma Unit, Dermatology Department, Hospital Clinic, Universitat de Barcelona, Institut d'investigacions biomèdiques August Pi i Sunyer (IDIBAPS), Barcelona, Spain. · Centro de Investigación Biomédica en Red (CIBER) de Enfermedades Raras, Barcelona, Spain. · Melanoma Unit, Medical-&-Surgical Dermatology Department, Hospital Universitario Virgen Macarena, Sevilla, Spain. · Unidad de Investigación, Fundación Piel Sana, Academia Española de Dermatología, Madrid, Spain. · Nuclear Medicine Department, Hospital Clinic Barcelona, Universitat de Barcelona, Institut d'investigacions biomèdiques August Pi i Sunyer (IDIBAPS), Barcelona, Spain. · Surgery Department, Hospital Clinic, Barcelona, Spain. · Pathology Department, Hospital Clinic, Universidad de Barcelona, Barcelona, Spain. · Dermatology Department, Instituto Valenciano de Oncología, Valencia, Spain. · Surgery Department, Instituto Valenciano de Oncología, Valencia, Spain. · Pathology Department, Instituto Valenciano de Oncología, Valencia, Spain. · Otorhinolaringology Department, Instituto Valenciano de Oncología, Valencia, Spain. · Pathology Department, Hospital Universitari Germans Trial i Pujol, Badalona, Spain. · Surgery Department, Hospital Universitari Germans Trial i Pujol, Badalona, Spain. · Medical Oncology Department, Institut Català d'Oncologia, Hospital Universitari Germans Trial i Pujol, Badalona, Spain. · Grupo de Investigación, Unidad de Gestión Clínica de Dermatología Médico-Quirúrgica, Hospital Universitario Virgen Macarena, Sevilla, Spain. · Pubmed 28960289
2017
  • Translational Genomics and Targeted Therapeutics in Solid Tumors, August Pi i Sunyer Biomedical Research Institute (IDIBAPS), Barcelona, Spain. · Medical Oncology Department, Hospital Clínic of Barcelona, Barcelona, Spain. · Translational Genomics Group, Vall d'Hebron Institute of Oncology (VHIO), Barcelona, Spain. · Medical Oncology Department, Vall d'Hebron Hospital, Barcelona, Spain. · Translational Genomics and Targeted Therapeutics in Solid Tumors, August Pi i Sunyer Biomedical Research Institute (IDIBAPS), Barcelona, Spain. · Molecular Oncology Group, Vall d'Hebron Institute of Oncology (VHIO), Barcelona, Spain. · Pathology Department, Hospital Clínic of Barcelona, Barcelona, Spain. · Department of Bioinformatics, Lineberger Comprehensive Cancer Center, Chapel Hill, North Carolina. · Cancer Genomics Group, Vall d'Hebron Institute of Oncology (VHIO), Barcelona, Spain. · Pubmed 28487385
2016
  • Hospital Clinic I Provincial de Barcelona, Universitat de Barcelona and Institut d'Investigacions Biomèdiques August Pi i Sunyer, Barcelona, Spain2Department of Dermatology, Post-Graduation Program in Pathology, Universidade Federal de Ciências da Saúde de Porto Alegre, Porto Alegre, Brazil3Pontifícia Universidade Católica do Rio Grande do Sul, School of Medicine, Porto Alegre, Brazil. · Hospital Clinic I Provincial de Barcelona, Universitat de Barcelona and Institut d'Investigacions Biomèdiques August Pi i Sunyer, Barcelona, Spain. · Department of Dermatology, Post-Graduation Program in Pathology, Universidade Federal de Ciências da Saúde de Porto Alegre, Porto Alegre, Brazil. · Hospital Clinic I Provincial de Barcelona, Universitat de Barcelona and Institut d'Investigacions Biomèdiques August Pi i Sunyer, Barcelona, Spain4Centro de Investigación Biomédica en Red en Enfermedades Raras, Barcelona, Spain. · Pubmed 27579522
  • Melanoma Unit, Dermatology Department, Hospital Clínic & IDIBAPS (Institut d'Investigacions Biomèdiques August Pi i Sunyer), Barcelona, Spain. · Department of Pathology, Hospital Clínic de Barcelona, Barcelona, Spain; Universitat de Barcelona, Barcelona, Spain. · Melanoma Unit, Dermatology Department, Hospital Clínic & IDIBAPS (Institut d'Investigacions Biomèdiques August Pi i Sunyer), Barcelona, Spain; Centro Investigación Biomédica en Red de Enfermedades Raras (CIBERER), Instituto de Salud Carlos III (ISCIII), Barcelona, Spain; Universitat de Barcelona, Barcelona, Spain. · Melanoma Unit, Dermatology Department, Hospital Clínic & IDIBAPS (Institut d'Investigacions Biomèdiques August Pi i Sunyer), Barcelona, Spain; Centro Investigación Biomédica en Red de Enfermedades Raras (CIBERER), Instituto de Salud Carlos III (ISCIII), Barcelona, Spain; Universitat de Barcelona, Barcelona, Spain. Electronic address: · Pubmed 27185448
2015
  • Melanoma Unit, Department of Dermatology, Hospital Clínic, Institut d'Investigacions Biomèdiques August Pi i Sunyer, University of Barcelona, Barcelona, Spain2Centro de Investigación Biomédica en Red en Enfermedades Raras, Instituto de Salud Carlos III, B. · Centro de Investigación Biomédica en Red en Enfermedades Raras, Instituto de Salud Carlos III, Barcelona, Spain3Department of Biochemical and Molecular Genetics, Hospital Clínic, Institut d'Investigacions Biomèdiques August Pi i Sunyer, University of Barc. · Department of Pathology, Hospital Clínic, Institut d'Investigacions Biomèdiques August Pi i Sunyer, University of Barcelona, Barcelona, Spain. · Pubmed 25651238
  • Melanoma Unit, Dermatology Department, Hospital Clinic of Barcelona, Barcelona, Spain; August Pi i Sunyer Biomedical Research Institute (IDIBAPS), Barcelona, Spain. · Pathology Department, Hospital Clinic of Barcelona, Barcelona, Spain. · Melanoma Unit, Dermatology Department, Hospital Clinic of Barcelona, Barcelona, Spain; August Pi i Sunyer Biomedical Research Institute (IDIBAPS), Barcelona, Spain; Centre of Biomedical Research on Rare Diseases (CIBERER), ISCIII, Barcelona, Spain. · Melanoma Unit, Dermatology Department, Hospital Clinic of Barcelona, Barcelona, Spain; August Pi i Sunyer Biomedical Research Institute (IDIBAPS), Barcelona, Spain; Centre of Biomedical Research on Rare Diseases (CIBERER), ISCIII, Barcelona, Spain; Department of Medicine, Universitat de Barcelona, Spain. Electronic address: · Pubmed 25500039
2014
  • Dermatology Department, Melanoma Unit, Hospital Clinic of Barcelona, Barcelona, Spain; Institut de Recerca Biomédica August Pi i Sunyer (IDIBAPS), Barcelona, Spain. · Dermatology Department, Melanoma Unit, Hospital Clinic of Barcelona, Barcelona, Spain; Institut de Recerca Biomédica August Pi i Sunyer (IDIBAPS), Barcelona, Spain; Centro de Investigación Biomédica en Red de Enfermedades Raras (CIBERER), Instituto de Salud Carlos III (ISCIII), Barcelona, Spain. · Pathology Department, Melanoma Unit, Hospital Clinic of Barcelona, Barcelona, Spain; Universitat de Barcelona, Barcelona, Spain. · Pathology Department, Melanoma Unit, Hospital Clinic of Barcelona, Barcelona, Spain. · Dermatology Department, Melanoma Unit, Hospital Clinic of Barcelona, Barcelona, Spain; Institut de Recerca Biomédica August Pi i Sunyer (IDIBAPS), Barcelona, Spain; Centro de Investigación Biomédica en Red de Enfermedades Raras (CIBERER), Instituto de Salud Carlos III (ISCIII), Barcelona, Spain; Universitat de Barcelona, Barcelona, Spain. Electronic address: · Pubmed 24725478
  • Department of Pathology, Hospital Clínic, IDIBAPS, University of Barcelona, Barcelona, Spain. · Department of Biochemical and Molecular Genetics, Hospital Clínic, IDIBAPS, University of Barcelona, Barcelona, Spain; Center for Biomedical Network Research on Rare Diseases (CIBERER), the Carlos III Institute of Health (ISCIII), Barcelona, Spain. · Center for Biomedical Network Research on Rare Diseases (CIBERER), the Carlos III Institute of Health (ISCIII), Barcelona, Spain; Department of Dermatology, Hospital Clínic, IDIBAPS, University of Barcelona, Barcelona, Spain. · Joseph Carreras Institute for Research against Leukemia, Hospital "Germans Trias i Pujol", Autonomous University of Barcelona, Barcelona, Spain. · Department of Pathology, Hospital Clínic, IDIBAPS, University of Barcelona, Barcelona, Spain. Electronic address: · Pubmed 24374110
  • Department of Pathology, Hospital Clínic, IDIBAPS, University of Barcelona, Spain. · Department of Biochemical and Molecular Genetics, Hospital Clínic, IDIBAPS, University of Barcelona, Spain; Centro Investigación Biomédica en Enfermedades Raras (CIBERER), Instituto de Salud Carlos III (ISCIII), Barcelona, Spain. · Institute of Predictive and Personalized Medicine of Cancer (IMPPC), Badalona, Spain. · Melanoma Unit, Department of Dermatology, Hospital Clínic, IDIBAPS, University of Barcelona, Spain; Centro Investigación Biomédica en Enfermedades Raras (CIBERER), Instituto de Salud Carlos III (ISCIII), Barcelona, Spain. · Institut de Recerca contra la Leucèmia Josep Carreras, Hospital Germans Trias i Pujol, Universitat Autònoma de Barcelona, Badalona, Spain. · Department of Pathology, Hospital Clínic, IDIBAPS, University of Barcelona, Spain. Electronic address: · Pubmed 25219713
2017
  • aMelanoma Unit, Department of Dermatology bMelanoma Unit, Department of Pathology cBiochemical and Molecular Genetics Service, Melanoma Unit, Hospital Clinic, Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS) dRadiotherapeutic Oncology Service, Melanoma Unit eGeneral Surgery Service, Melanoma Unit fImaging Diagnostic Center, CDI (Radiology and Nuclear Medicine Services), Melanoma Unit, Hospital Clinic gBiomedical Research Center for Rare Diseases, CIBERER. Insituto de Salud Carlos III hMedicine Department, University of Barcelona, Barcelona, Spain. · Pubmed 28296711
  • Dermatology Department, Melanoma Unit, Hospital Clinic and IDIBAPS (Institut d'Investigacions Biomèdiques August Pi i Sunyer, Barcelona, Spain. · Pubmed 27353949
2015
  • Melanoma Unit, Dermatology Department, Hospital Clinic of Barcelona, IDIBAPS, Barcelona, Spain. · Pubmed 25394499
2013
  • Melanoma Unit, Department of Dermatology, Hospital Clinic, Institut d'Investigacions Biomèdiques August Pi i Sunyer, Barcelona, Spain2Centro de Investigacion Biomedica en Red Enfermedades Raras, Instituto de Salud Carlos III, Barcelona, Spain. · Pubmed 23863988
2012
  • Melanoma Unit, Dermatology Department, Hospital Clìnic of Barcelona, IDIBAPS, Barcelona, Spain. · Pubmed 22521205
2011
  • Department of Pathology, Hospital Clínic, Institut d'Investigacions Biomèdiques August Pi i Sunyer, University of Barcelona, Spain. · Pubmed 21997694
  • Melanoma Unit, Department of Dermatology, Hospital Clinic of Barcelona, Institut d'investigacions Biomèdiques August Pi i Sunyer, Barcelona, Spain. · Pubmed 21281387
  • Department of Dermatology, Melanoma and Dermatopathology Units, Hospital Clínic de Barcelona, Universitat de Barcelona, Barcelona, Spain. · Pubmed 21240454
Instituto de Salud Carlos III
2017
  • aMelanoma Unit, Department of Dermatology bMelanoma Unit, Department of Pathology cBiochemical and Molecular Genetics Service, Melanoma Unit, Hospital Clinic, Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS) dRadiotherapeutic Oncology Service, Melanoma Unit eGeneral Surgery Service, Melanoma Unit fImaging Diagnostic Center, CDI (Radiology and Nuclear Medicine Services), Melanoma Unit, Hospital Clinic gBiomedical Research Center for Rare Diseases, CIBERER. Insituto de Salud Carlos III hMedicine Department, University of Barcelona, Barcelona, Spain. · Pubmed 28296711
Yearly article counts 01333311300
Remember this Person You can save this page -- like a bookmark -- so it's remembered for you on the Expertscape "Saved Pages" page, which is always easily available from the page-top menu bar throughout the site.